Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BI 14332 CL Food Effect Study in Healthy Volunteers
NCT02212938Phase 1Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Sep 2006
- Primary completion
- Nov 2006
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of telmisartan in hypertension (HTN), sponsored by Boehringer Ingelheim. Primary endpoint: Area under the concentration-time curve from 0 to infinity at 192 hours. Started Sep 2006; status: completed.
02
Drugs
telmisartan
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT02212938.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02212938.